MGMT and glioblastoma: In total, 769 patients with newly diagnosed, contrast enhancing glioblastoma were screened, of whom we excluded 333 patients: 22 were excluded due to IDH mutation and 311 were excluded due to insufficient or missing molecular data on IDH mutation or MGMT methylation status.